Does the Incremental Shuttle Walk Test Predict the Development of a Hospital Acquired Pneumonia in Patients Undergoing Elective Oesophagectomy: A Prospective Cohort Study
NCT04440124 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 121
Last updated 2020-06-19
Summary
The purpose of this study was to assess the predictive value of the incremental shuttle walk test on rates of hospital acquired pneumonia for patients undergoing oesophagectomy.
Conditions
- Oesophageal Cancer
Interventions
- OTHER
-
Incremental shuttle walk test
All patients were reviewed by a physiotherapist during their pre-assessment clinic one week prior to surgery to complete an incremental shuttle walk test (ISWT). The ISWT was completed according to a standardised protocol and involved patients walking around 2 cones set up 9 metres apart. Patients were asked to cover the distance between the cones in time to auditory cues. Oxygen levels and heart rate were recorded during the assessment with the use of a portable pulse oximeter. The test was stopped when patients could no longer keep pace with the auditory cues or were too breathless to continue. The total distance mobilised was recorded.
Sponsors & Collaborators
-
University Hospital Birmingham NHS Foundation Trust
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2017-12-01
- Primary Completion
- 2020-02-01
- Completion
- 2020-02-01
Countries
- United Kingdom
Study Locations
More Related Trials
-
Palliative Short-course Hypofractionated Radiotherapy Followed by Chemotherapy in Adenocarcinoma of the Esophagus or Esophagogastric Junction Trial - a Phase II Clinical Trial Protocol.
NCT02241499 ·Status: COMPLETED ·Phase: PHASE2
-
Dose Escalation of Neoadjuvant Proton Beam Radiotherapy With Concurrent Chemotherapy in Locally Advanced Esophageal Cancer
NCT02213497 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
Neoadjuvant Immunotherapy (PD-1 / PD-L1) Combined With Chemotherapy for Locally Advanced Thoracic Esophageal Squamous Cell Carcinoma: a Single Center, Prospective, Open, One Arm Exploratory Clinical Study
NCT05028231 ·Status: UNKNOWN
-
Impact of Prehabilitation in Oncology Via Exercise- Esophageal (IMPROVE-Esophageal)
NCT06872515 ·Status: RECRUITING ·Phase: NA
-
Study on Adjuvant Chemotherapy After Total Two-field Lymph Node Dissection of Thoracic Esophageal Squamous Cell Carcinoma
NCT04174079 ·Status: RECRUITING ·Phase: NA
-
PET/CT-directed Hyperfractionated Radiation Dose Escalation in Esophageal Cancer
NCT03113214 ·Status: COMPLETED ·Phase: NA
-
Positron Emission Tomography in Determining Stage of Esophageal Cancer
NCT00004867 ·Status: COMPLETED ·Phase: NA
-
Combination Chemotherapy in Treating Patients With Esophageal Cancer
NCT00041262 ·Status: UNKNOWN ·Phase: PHASE3
-
Pembrolizumab, Radiotherapy, and Chemotherapy in Neoadjuvant Treatment of Malignant Esophago-gastric Diseases (PROCEED)
NCT03064490 ·Status: COMPLETED ·Phase: PHASE2
-
Effect of Concurrent Chemoradiation Therapy on Respiratory Muscle Performance, Lung Function and Functional Capacity in Patients With Local Esophagus Cancer
NCT03120572 ·Status: COMPLETED
-
Phase II Trial of Neoadjuvant Treatment and Minimal Invasive Surgery for Esophageal and GEJ Cancer
NCT02924909 ·Status: UNKNOWN ·Phase: PHASE2
-
Neoadjuvant Chemotherapy With Camrelizumab in Locally Advanced Esophageal Squamous Cell
NCT04520035 ·Status: UNKNOWN ·Phase: PHASE2
-
Computed Tomography in Detecting Movement of the Esophagus in Patients Undergoing Radiation Therapy to the Chest
NCT00433524 ·Status: COMPLETED ·Phase: NA
-
A Study Involving Neoadjuvant Chemoradiotherapy with Hypofractionated Radiotherapy in Patients with Esophageal and Gastroesophageal Junction Adenocarcinoma
NCT05370144 ·Status: RECRUITING ·Phase: NA
-
AK104 Plus Concurrent Chemoradiation Therapy in Esophageal Squamous Cell Carcinoma
NCT05594914 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Neoadjuvant Therapy for Esophageal Cancer and Cardiopulmonary Physiology
NCT03462524 ·Status: COMPLETED
-
Incidence of 106TBL Lymph Node Metastasis
NCT07165210 ·Status: RECRUITING
-
Feasibility and Safety of Using Nasal High Flow Oxygen Postoperatively to Reduce Respiratory Complications
NCT04272268 ·Status: WITHDRAWN
-
Neoadjuvant Immunotherapy Combined With Chemotherapy in Patients With Locally Advanced ESCC
NCT05807542 ·Status: COMPLETED ·Phase: PHASE2
-
Different Radiation Dose With Concurrent Chemotherapy for Thoracic Esophageal Carcinoma
NCT02850991 ·Status: COMPLETED ·Phase: NA
-
CCRT With Twice Weekly Paclitaxel and Cisplatin Followed by Surgery for Locally Advanced Esophageal Cancer
NCT00154804 ·Status: COMPLETED ·Phase: PHASE2
-
Phase II/III Study Compare Adjuvant Chemoradiotherapy, Radiotherapy and Surgery Alone for Esophageal Carcinoma
NCT02279134 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Neoadjuvant Anti-PD-1 Plus Chemotherapy in Locally Advanced Resectable Esophageal Squamous Cell Carcinoma
NCT05740995 ·Status: RECRUITING
-
Salvage Chemoradiation Therapy for Recurrence After Radical Surgery or Palliative Surgery in Esophageal Cancer Patients
NCT03731442 ·Status: RECRUITING ·Phase: PHASE3
-
Detection of (Sub)Clinical Toxicity in Irradiated vs. Non-irradiated Surgically Treated Esophageal Cancer Patients: a Pilot Study (CROSS SECT)
NCT03396614 ·Status: COMPLETED